Assisted Psychedelic Psychotherapy: Rethinking the Paradigms of Psychiatric Care? DOI Creative Commons

Eliana Mea,

Paola Clemente

IntechOpen eBooks, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 20, 2024

Can psychedelic-assisted psychotherapy (PAT) serve as a paradigm for describing and navigating profound transformative experience of the self? This model therapy has ignited an intense debate in recent years that seems aimed at calling into question, more than various currents psychotherapy, psychiatric care lost over time real capacity to address psychological distress people interpret phenomena observed, too often reducing itself aseptic prescription drugs which therapeutic relationship progressively become emptied meaning. In this work, we will examine current schools thought animate on PAT psychodynamic aspects allow us better understand functioning specific psychotherapeutic approach. According psycholytic paradigm, psychedelic substances are capable inducing regression states consciousness different from its ordinary state. such states, fundamental conflicts may emerge early life have led development ego realized adaptive functions external environment with or less functional configurations. Is it possible through type approach access temporary psychic deintegration then arrive new integrative modalities broaden subject’s self-awareness?

Language: Английский

Sex and psychedelics: a wide-lens look at a burgeoning field DOI
Alex Dymock, Zoé Dubus

Medical Humanities, Journal Year: 2025, Volume and Issue: unknown, P. medhum - 013068

Published: Jan. 6, 2025

In this article we initiate a conversation between scientific and humanities-oriented studies of sexuality psychedelics. Drawing on three recent which indicate positive connection the use psychedelics sexual well-being, argues that taking account as culturally produced, historically contingent geographically specific would improve reliability efficacy future studies. The need for socially attuned research grounded in contemporary politics area is urgent, years—despite little reporting clinical research—the field has had to grapple with ethics relationship psychedelic states interactions therapeutic spaces ‘underground’. There also scant attention date paid gendered dynamics sex sexuality, how may impact perceptions repair versus enhancement. We unpack some these dilemmas outline key concerns potential priorities into post-#MeToo era.

Language: Английский

Citations

1
Further education in psychedelic-assisted therapy – experiences from Switzerland DOI Creative Commons
Helena D. Aicher, Felix Müller,

Peter Gasser

et al.

BMC Medical Education, Journal Year: 2025, Volume and Issue: 25(1)

Published: March 5, 2025

The growing interest in psychedelic-assisted therapy (PAT) for treating psychiatric disorders such as treatment-resistant depression, PTSD, and anxiety has led to an increasing demand specialized training. In Switzerland, MDMA, psilocybin, LSD are applied the framework of limited medical use exceptional treatment options since 2014. Swiss Medical Association Psychedelic Therapy (SÄPT) been a key player addressing need education, offering comprehensive, three-year training program physicians psychologists. This curriculum integrates theoretical knowledge with hands-on experience, emphasizing therapeutic relationship, ethical considerations, management altered states consciousness induced by psychedelics. article gives overview structure addresses topics covered through teaching retreats focusing on practical learning. However, these programs far exceeds supply. gap is expected widen psychedelics potentially become regulated prescription medications. response, several organizations have expanded their educational offerings, including further education trainings, workshops, conferences, symposia. Overall, there more comprehensive accessible meet demand. evolving landscape psychedelic research, regulatory changes, diverse patient populations require flexible adaptive models. As field progresses, it essential establish certification standards ensure continued quality safe effective PAT clinical trials practice.

Language: Английский

Citations

0
Metacognitive Feelings of Epistemic Gain are Central to the Understanding of Psychedelic-Induced Mystical-Type Experiences DOI Creative Commons
Federico Seragnoli, Fabienne Picard, Gabriel Thorens

et al.

Cognitive Therapy and Research, Journal Year: 2025, Volume and Issue: unknown

Published: March 29, 2025

Language: Английский

Citations

0
Attitudes and Perceptions of Portuguese Psychiatrists and Psychologists on the Clinical Use of Ketamine DOI Creative Commons
Pedro Mota, Jorge Encantado, Lina Carvalho

et al.

Acta Médica Portuguesa, Journal Year: 2025, Volume and Issue: 38(5), P. 297 - 306

Published: May 2, 2025

Introduction: Ketamine has garnered attention for its rapid efficacy in alleviating depressive symptoms treatment-resistant depression, offering a novel mechanism as non-monoaminergic agent. Despite potential, limited research explored mental health professionals’ perspectives on use. This study assesses the attitudes, knowledge, and concerns of Portuguese psychiatrists psychologists regarding clinical application ketamine depression.Methods: A cross-sectional survey was conducted from June 2022 to January 2024 among psychologists. The anonymous online questionnaire assessed perceptions ketamine’s therapeutic utility, risks, knowledge sources. Statistical analyses examined subgroup differences by age, sex, profession, prior psychedelic use.Results: Among 156 participants (mean age = 37.2; 68.6% female), 53.8% were psychologists, 46.2% or trainees Psychiatry. Only 35.9% reported substantial while 59% open integrating it clinically. majority expressed interest training, though 73% raised about inadequate professional training. Significant emerged, with reporting higher levels openness compared younger professionals showed greater training usage.Conclusion: There favorable attitude toward use yet educational gaps remain. Customized addressing background is essential safe effective integration depression. Further studies should focus longitudinal outcomes treatment under standardized protocols ensure safety practice.

Language: Английский

Citations

0
Serotonergic psychedelics for depression: A comprehensive overview DOI
Aleksandra Wingert,

C. Agnorelli,

Joseph Peill

et al.

International review of neurobiology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

0
Psychothérapie assistée par psychédéliques (PAP) : le modèle genevois DOI Creative Commons
Federico Seragnoli, Gabriel Thorens, Louise Penzenstadler

et al.

Annales Médico-psychologiques revue psychiatrique, Journal Year: 2024, Volume and Issue: 182(9), P. 806 - 813

Published: July 10, 2024

Dans cet article, nous avons pour objectif de décrire un modèle interdisciplinaire psychothérapie assistée par psychédéliques (PAP) que développé dans cadre institutionnel aux hôpitaux universitaires Genève. La est une approche psychothérapeutique exploitant l'altération l'état conscience induite substance psychédélique. Cette approche, longtemps négligée des raisons historiques non scientifiques, fait nouveau l'objet recherches grâce à résultats préliminaires importants concernant son potentiel thérapeutique divers troubles mentaux. En Suisse, depuis 2014, il possible d'obtenir autorisations médicales exceptionnelles traiter patients avec du LSD et la psilocybine. Nous soutenons les outil puissant qui pourrait être appuyer traditionnelle basée sur le dialogue afin relancer processus psychothérapeutique. In this we aim to describe an interdisciplinary model for psychedelic assisted psychotherapy that have developed at the Geneva University Hospitals, in institutional setting. Our integrates collaborative efforts of psychiatrists, psychologists, and nurses establishing a structured framework administering PAP safe, controlled, standardized manner. Psychedelic is psychotherapeutic approach utilizes profound alteration state consciousness induced by substances enhance therapeutic outcomes. This innovative approach, which has been neglected due historical biases rather than empirical evidence, now experiencing renewed interest among clinicians. Contemporary research, equipped with advanced methodologies rigorous scientific showing significant potential range mental health disorders. Switzerland, legal authorizes medicinal use since 2014 exceptional authorizations psilocybin purposes, under strict regulations. We provide comprehensive description protocol implemented beginning its inception September 2020. methodological outline includes administrative clinical selection criteria patient eligibility; preparatory sessions designed introduce psychoeducation interventions analysis intention therapeutical objectives; controlled administration psychedelics supportive environment; integration follow experiences. emphasizes safety, ethical considerations, importance relationship throughout process. also questionnaires qualify assess consciousness, namely The Five Dimension Altered States Consciousness (5AD-ASC) Mystical Experience Questionnaire (MEQ). Since start program 2020 up February 2024, total 224 personal (114 LSD, 110 Psilocybin) issued Hospital team, 396 individual sessions. core argument presented article psychedelic-induced novel tool, works as potent catalyst can be synergistically combined traditional dialogue-based psychotherapy. combination support processes enable breakthroughs cases where conventional therapy reached limits. discuss implications reflecting on both challenges transformative within application. conclusion our endorsement continued basic research PAP. By presenting detailed process, including preparatory, experiential, integrative phases, advocate scientifically grounded exploration efficacy. calls broader acceptance practice, provided it underpinned ongoing support.

Citations

2
Psychedelic‐assisted therapy for palliative care within a home treatment setting: A case report DOI Creative Commons
Federico Seragnoli,

Martignoni Geo,

Martignoni Entela

et al.

Clinical Case Reports, Journal Year: 2024, Volume and Issue: 12(9)

Published: Aug. 30, 2024

Key Clinical Message This case study describes the feasibility and safety of psychedelic‐assisted therapy (PAT) as a home‐based intervention for patient with throat cancer experiencing significant existential distress. The tolerated well. supports PAT patients life‐threatening conditions in home setting. Abstract Psychedelic‐assisted (PAT), it is practiced today, merges traditional psychotherapeutic techniques use psychedelics such LSD, psilocybin, or MDMA aim unlocking deeper insights treating mental that are resistant to other forms therapy. present well was asked report on measures anxiety, depression, distress related his somatic condition. observations provided by this clinical align previous findings, suggesting can be safely applied potentially provide relief from conditions. As single‐case study, generalizations should made cautiously. Moreover, placebo effects, expectancy natural course disease may influence outcomes. Future research consider controlled trials ascertain efficacy interventions diverse settings.

Language: Английский

Citations

0
Assisted Psychedelic Psychotherapy: Rethinking the Paradigms of Psychiatric Care? DOI Creative Commons

Eliana Mea,

Paola Clemente

IntechOpen eBooks, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 20, 2024

Can psychedelic-assisted psychotherapy (PAT) serve as a paradigm for describing and navigating profound transformative experience of the self? This model therapy has ignited an intense debate in recent years that seems aimed at calling into question, more than various currents psychotherapy, psychiatric care lost over time real capacity to address psychological distress people interpret phenomena observed, too often reducing itself aseptic prescription drugs which therapeutic relationship progressively become emptied meaning. In this work, we will examine current schools thought animate on PAT psychodynamic aspects allow us better understand functioning specific psychotherapeutic approach. According psycholytic paradigm, psychedelic substances are capable inducing regression states consciousness different from its ordinary state. such states, fundamental conflicts may emerge early life have led development ego realized adaptive functions external environment with or less functional configurations. Is it possible through type approach access temporary psychic deintegration then arrive new integrative modalities broaden subject’s self-awareness?

Language: Английский

Citations

0